Moonshot AI targets a $30 billion valuation, more than six times its late-2025 worth

The valuation jump matters less as a headline number and more as a signal about where late-stage private capital is flowing: away from US-centric bets and toward Chinese frontier labs that have demonstrated regional product traction, not just benchmark performance.

This sits directly alongside the broader capital mobilization story we covered in early June. Alphabet's $80 billion raise for AI infrastructure and Anthropic's IPO filing (covered via both The Decoder and WIRED on June 1) illustrate that the funding arms race is no longer confined to US incumbents. What's notable is that Moonshot AI is repricing on the private side while Western labs are moving toward public markets, suggesting two divergent capital strategies are emerging in parallel. The Nvidia Nemotron story from June 1 also provides useful framing: if Chinese models still lead on key benchmarks despite US labs closing the gap, investors backing Moonshot are betting that benchmark leadership converts to durable commercial advantage in Asian markets.

Watch whether Moonshot AI closes this round at or above the $30 billion target within the next two quarters. A haircut on final terms would suggest investor enthusiasm is softer than the headline implies; a close at full valuation would confirm that non-US frontier labs are now genuinely competing for the same capital pools as their Western counterparts.